BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
Information Commissioner's Office |
||
|
You are here: BAILII >> Databases >> Information Commissioner's Office >> Medicines and Healthcare Products Regulatory Agency (Decision Notice) [2006] UKICO FS50072939 (12 June 2006) URL: http://www.bailii.org/uk/cases/UKICO/2006/FS50072939.html Cite as: [2006] UKICO FS50072939 |
||
[New search] [Printable PDF version] [Help]
Summary: The complainant requested names of individuals referred to in documents held by the MHRA about a specific product, rofecoxib. The MHRA refused to disclose this information on the grounds that it was exempt under section 38 (Health and Safety) and section 36 (Prejudice to the Effective Conduct of Public Affairs). The Commissioner has decided that section 38 has been correctly applied by the MHRA and that the public interest in withholding the information outweighs the public interest in disclosure, and so the Agency was justified in withholding information revealing the names of individuals in a way that links them to a specific product, inspection or investigation. As the Commissioner decided that the information was exempt under section 38, he has considered the application of section 36 in Decision Notice.
Section of Act/EIR & Finding: FOI 38 - Complaint Not upheld
